BCBS更新政策,要求一些哮喘病人从4月15日起在家自行自药。 BCBS updates policy, requiring some asthma patients to self-administer drugs at home, starting April 15.

蓝十字蓝盾(Blue Cross Blue Shield)正在改变其政策, 于4月15日(2025年)生效, 要求一些哮喘病人自行服药, Blue Cross Blue Shield is changing its policy, effective April 15, 2025, to require some asthma patients to self-administer medications like Fasenra, Tezspire, Nucala, and Xolair at home instead of clinics. BCBS将根据医疗需要更新覆盖范围标准。 BCBS will update coverage criteria based on medical necessity. 像Maya Gharfeh博士这样的医生担心过敏反应和病人的坚持。 Doctors like Dr. Maya Gharfeh worry about allergic reactions and patient adherence. BCBS指出,修改的目的是扩大获得保健服务的机会。 BCBS states the changes aim to expand access to healthcare.